AFT Pharmaceuticals - Solid FY20 results
AFT Pharmaceuticals recently reported its FY20 results. Operating revenue grew by a strong 24.0% year-on-year to NZ$105.6m as there was at least...
118 Views
AFT Pharmaceuticals - A strong start to FY20
AFT Pharmaceuticals is a New Zealand-based specialty pharmaceutical company that currently sells over 130 prescription specialty generics and OTC...
791 Views
AFT Pharmaceuticals - Margins improving
AFT Pharmaceuticals recently reported its H119 results. Operating revenue grew 4.1% compared to H118 and was negatively affected by the divestment...
85 Views
AFT Pharmaceuticals - Improving profitability
AFT recently announced an agreement with Baxter Healthcare to divest to Baxter some of its non-core and low-margin hospital products in New...
138 Views
AFT Pharmaceuticals - Australia and Maxigesic driving growth
AFT Pharmaceuticals is a New Zealand-based specialty pharmaceutical company that currently sells over 130 prescription specialty generics and OTC...
126 Views